Browsing Centre for Biochemical Pharmacology by Author "Hansen, S"
Now showing items 1-6 of 6
-
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry.
Scelo, G; Torres-Duque, CA; Maspero, J; Tran, TN; Murray, R; Martin, N; Menzies-Gow, AN; Hew, M; Peters, MJ; Gibson, PG (2023-08-26)BACKGROUND: Investigation for the presence of asthma comorbidities is recommended by GINA as their presence can complicate asthma management. OBJECTIVE: To understand the prevalence and pattern of comorbidities and ... -
Association between pre-biologic T2-Biomaker combinations and response to biologics in patients with severe asthma
Porsbjerg, CM; Townend, J; Bergeron, C; Christoff, GC; Katsoulotos, GP; Larenas-Linnemann, D; Tran, TN; Al-Lehebi, R; Bosnic-Anticevich, SZ; Busby, J -
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma.
Wechsler, ME; Scelo, G; Larenas-Linnemann, DES; Torres-Duque, CA; Maspero, J; Tran, TN; Murray, RB; Martin, N; Menzies-Gow, AN; Hew, M (2023-11-28)RATIONALE: Previous studies investigating comorbidity impact on biologic effectiveness have been relatively small, of short duration, and have not compared biologic classes. OBJECTIVES: To determine the association between ... -
Biomarker-defined clusters by level of Type 2 inflammatory involvement in severe asthma
Price, D; Burkill, S; Wang, E; Wechsler, ME; Denton, E; Tran, TN; Martin, N; Katial, R; Barker, P; Maspero, J (2022) -
Prevalence of Comorbidities in Adults with Severe Asthma: Results from the International Severe Asthma Registry (ISAR)
Scelo, G; Porsbjerg, CM; Carter, V; Ariti, C; Lyu, J; Eleangovan, N; Tran, TN; Barker, P; Katial, R; Martin, N (2022) -
Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
Burkill, S; Porsbjerg, CM; Bourdin, A; Tran, TN; Martin, N; Katial, R; Barker, P; Wechsler, ME; Maspero, J; Bosnic-Anticevich, S (2022)